Institution Directory

Clinical trials at Weill Cornell Medicine

Sites in New York, NY

Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 6:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official matching trials

778

Shown on this page

Current sort

Live official records

Conditions: Breast Cancer
Interventions: Abemaciclib, Standard Adjuvant Endocrine Therapy; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 5,637 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2029
U.S. locations: 162
States / cities: Birmingham, Alabama • Anchorage, Alaska • Gilbert, Arizona + 104 more

Conditions: Obesity, Weight Loss, Gastro Esophageal Reflux, Bariatric Surgery Candidate
Interventions: Endoscopic Bariatric Therapies; Other
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 89 Years
Enrollment: 9,999 participants
Timeline: 2016 – 2035
U.S. locations: 1
States / cities: New York, New York

Conditions: Esophageal Adenocarcinoma, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
Interventions: OBP-301, Pembrolizumab; Drug
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2030
U.S. locations: 2
States / cities: New York, New York • Philadelphia, Pennsylvania

Conditions: Prostate Cancer
Interventions: Robot-assisted radical prostatectomy (RP), Pelvic fascia-sparing robot-assisted radical prostatectomy (PFS-RP); Procedure
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 40 Years to 80 Years · Male only
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 9
States / cities: Duarte, California • Washington D.C., District of Columbia • Chicago, Illinois + 5 more

Conditions: CABG Graft Integrity, CABG, Blood Flow, Transit-time Flow Measurement, Heart Disease
Interventions: Transit-Time Flow Measurement (TTFM); Device
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 1,242 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 1
States / cities: New York, New York

Conditions: Gestational Hypertension
Interventions: Nokia-Withings BPM Connect Blood Pressure Monitor, Smartwatch Devices; Device
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Nail Biting
Interventions: HabitAware group; Device
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 95 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Esophageal Adenocarcinoma, Esophageal Cancer, HER-2 Protein Overexpression, Gastroesophageal-junction Cancer
Interventions: Nivolumab, Trastuzumab deruxtecan; Drug
Lead sponsor: Brown University; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: New York, New York • Providence, Rhode Island

Conditions: Carcinoma, Non-Small-Cell Lung
Interventions: Cemiplimab, Platinum based chemotherapy, Stereotactic body radiation therapy; Drug · Radiation
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2032
U.S. locations: 1
States / cities: New York, New York

Conditions: Allergic Reactions
Interventions: Neffy, Adrenaline; Drug
Lead sponsor: ARS Pharmaceuticals, Inc.; Industry
Eligibility: 4 Years and older
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 6
States / cities: La Jolla, California • Washington D.C., District of Columbia • Glenview, Illinois + 3 more

Conditions: Prostate Cancer
Interventions: 225Ac-J591, Pembrolizumab, Androgen receptor inhibitor, 68Ga-PSMA-11; Drug · Diagnostic Test
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2029
U.S. locations: 4
States / cities: Boston, Massachusetts • Brooklyn, New York • New York, New York

Conditions: Parkinson Disease
Interventions: CVN424 75 mg, CVN424 150 mg, Placebo; Drug
Lead sponsor: Cerevance; Industry
Eligibility: 30 Years and older
Enrollment: 330 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 53
States / cities: Birmingham, Alabama • Phoenix, Arizona • Aliso Viejo, California + 41 more

About this Weill Cornell Medicine institution page

What this page lists: ClinicalTrials.gov records that list Weill Cornell Medicine in New York, NY as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status: A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from: Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do: No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.

Clinical trials at Weill Cornell Medicine

Filter and sort this campus

Live official records

Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer

Endoscopic Bariatric Therapies (EBTs): A Retrospective and Prospective Multicenter Registry

Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma

Clinical Trial of Approaches to Prostate Cancer Surgery

The Relationship Between Blood Flow Readings During Surgery and How Well the Graft Stays Open and How Patients Recover Afterward in Coronary Artery Bypass Graft Surgery

Digital Solutions to Reduce Maternal Morbidity and Mortality in Pregnant Refugee Women

Habit Awareness Device for Treatment of Onychophagia

Adjuvant Trastuzumab Deruxtecan (Enhertu) & Nivolumab For Patients Who Are Disease Free After Completion of Trimodality Treatment For HER-2+ Cancers of Esophagus & Gastroesophageal Junction

Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC

Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy

Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer

To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications

About this Weill Cornell Medicine institution page